Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections

Antimicrobial resistance in gram-negative pathogens, such as Acinetobacter baumannii, is a serious threat to human health. Sulbactam-durlobactam, a unique β-lactam and a β-lactamase inhibitor combination, is a novel agent targeted against carbapenem-resistant A. baumannii. This supplement provides a...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Richard R, Bonomo, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
SUL-DUR Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150272/
https://www.ncbi.nlm.nih.gov/pubmed/37125465
http://dx.doi.org/10.1093/cid/ciad093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150272/
https://www.ncbi.nlm.nih.gov/pubmed/37125465
http://dx.doi.org/10.1093/cid/ciad093

Ejemplares similares